Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 14 filers reported holding Astellas Pharma Inc in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,631,000 | +22.8% | 442,510 | +4.7% | 0.04% | +8.3% |
| Q4 2018 | $5,398,000 | -29.6% | 422,580 | -3.9% | 0.04% | -20.0% |
| Q3 2018 | $7,673,000 | -27.0% | 439,736 | -36.2% | 0.04% | -30.8% |
| Q2 2018 | $10,504,000 | +1.6% | 688,842 | -0.2% | 0.06% | -5.8% |
| Q1 2018 | $10,338,000 | +21.9% | 690,413 | +3.8% | 0.07% | +16.9% |
| Q4 2017 | $8,484,000 | – | 665,073 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RENAISSANCE GROUP LLC | 391,745 | $5,438,880 | 0.25% |
| Cassady Schiller Wealth Management, LLC | 698 | $9,667 | 0.01% |
| MAI Capital Management | 19,087 | $264,362 | 0.00% |
| SVB WEALTH LLC | 10,472 | $145,037 | 0.00% |
| RHUMBLINE ADVISERS | 34,759 | $481,408 | 0.00% |
| First Horizon Advisors, Inc. | 114 | $1,578 | 0.00% |
| Operose Advisors LLC | 90 | $1,247 | 0.00% |
| Russell Investments Group, Ltd. | 783 | $10,845 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 166 | $2,299 | 0.00% |